Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Citi
Chubb
Dow
McKinsey
US Army
Julphar
QuintilesIMS
Baxter
Merck

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017963

« Back to Dashboard

NDA 017963 describes LOPRESSOR, which is a drug marketed by Novartis and Us Pharms Holdings I and is included in four NDAs. It is available from three suppliers. Additional details are available on the LOPRESSOR profile page.

The generic ingredient in LOPRESSOR is hydrochlorothiazide; metoprolol tartrate. There are thirty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.

Summary for 017963

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 017963

Mechanism of ActionAdrenergic beta-Antagonists

Suppliers and Packaging for NDA: 017963

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LOPRESSOR metoprolol tartrate TABLET;ORAL 017963 NDA Medi-Physics Inc. 17156-601 17156-601-51 1 KIT in 1 CARTON (17156-601-51) * 1 mL in 1 APPLICATOR * 5 VIAL, GLASS in 1 BOX > 20 mL in 1 VIAL, GLASS
LOPRESSOR metoprolol tartrate TABLET;ORAL 017963 NDA Medi-Physics Inc. 17156-602 17156-602-52 1 KIT in 1 CARTON (17156-602-52) * 1 mL in 1 APPLICATOR * 5 VIAL, GLASS in 1 BOX > 20 mL in 1 VIAL, GLASS

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 017963

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharms Holdings ILOPRESSORmetoprolol tartrateTABLET;ORAL017963-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharms Holdings ILOPRESSORmetoprolol tartrateTABLET;ORAL017963-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharms Holdings ILOPRESSORmetoprolol tartrateTABLET;ORAL017963-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharms Holdings ILOPRESSORmetoprolol tartrateTABLET;ORAL017963-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Covington
Citi
Accenture
McKesson
Argus Health
Healthtrust
Fuji
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot